Skip to main content
Top
Published in: Endocrine 2/2014

01-11-2014 | Original Article

Sex hormone-binding globulin (SHBG) as an independent determinant of bone mineral density (BMD) among Chinese middle-aged and elderly men

Authors: Xiao-Yun Zha, Yu Hu, Xiao-Na Pang, Ji-Heng Zhu, Gui-Lin Chang, Li Li

Published in: Endocrine | Issue 2/2014

Login to get access

Abstract

The aim of the study was to assess the impact of sex hormone-binding globulin (SHBG) on bone mineral density (BMD) and bone turnover among Chinese middle-aged and elderly men. This cross-sectional study was carried out among 404 Chinese men aged over 45 years. BMD was measured with dual-energy X-ray absorptiometry, and participants’ blood was collected for bone-specific alkaline phosphates (BSAP), SHBG and testosterone assay. Osteoporotic men had lower free testosterone (FT) and higher levels of SHBG, and BSAP than the osteopenia and normal groups. When SHBG levels were divided into quartiles, FT levels decreased and prevalence of osteoporosis increased with higher SHBG levels. Compared with subjects in the lowest quartile of SHBG levels (<36.55 nmol/l), subjects in the third quartile [OR (95 % CI) 2.998 (1.460–6.157), p = 0.002] and the highest quartile [OR (95 % CI) 4.439 (2.192–8.991), p < 0.001] were more likely to suffer with osteoporosis. FT was significantly positive related to total hip BMD and total lumbar BMD, whereas there was no association between TT and BMD after adjusting for age, BMI and FT. SHBG levels were also inversely related to BMD. SHBG could explain 1.4–2.1 % of the BMD variance after adjustment for age, BMI and FT. No association was found between BSAP and SHBG, TT and FT. Logistic regression analysis showed that BMI, smoking and FT or SHBG was independently associated with the presence of osteoporosis. Serum FT levels were positively correlated with BMD, while SHBG levels were inversely related to BMD. Increasing SHBG level was an independent risk factor for osteoporosis among Chinese men.
Literature
1.
go back to reference Prevention and management of osteoporosis. World Health Organ. Tech. Rep. Ser. 921, 1–164 (2003) Prevention and management of osteoporosis. World Health Organ. Tech. Rep. Ser. 921, 1–164 (2003)
3.
go back to reference B. Frenkel, A. Hong, S.K. Baniwal, G.A. Coetzee, C. Ohlsson, O. Khalid, Y. Gabet, Regulation of adult bone turnover by sex steroids. J. Cell. Physiol. 224, 305–310 (2010)PubMedCrossRef B. Frenkel, A. Hong, S.K. Baniwal, G.A. Coetzee, C. Ohlsson, O. Khalid, Y. Gabet, Regulation of adult bone turnover by sex steroids. J. Cell. Physiol. 224, 305–310 (2010)PubMedCrossRef
5.
go back to reference P.K. Siiteri, J.T. Murai, G.L. Hammond, J.A. Nisker, W.J. Raymoure, R.W. Kuhn, The serum transport of steroid hormones. Recent Prog. Horm. Res. 38, 457–510 (1982)PubMed P.K. Siiteri, J.T. Murai, G.L. Hammond, J.A. Nisker, W.J. Raymoure, R.W. Kuhn, The serum transport of steroid hormones. Recent Prog. Horm. Res. 38, 457–510 (1982)PubMed
6.
go back to reference T.K. Andreassen, The role of plasma-binding proteins in the cellular uptake of lipophilic vitamins and steroids. Horm. Metab. Res. 38, 279–290 (2006)PubMedCrossRef T.K. Andreassen, The role of plasma-binding proteins in the cellular uptake of lipophilic vitamins and steroids. Horm. Metab. Res. 38, 279–290 (2006)PubMedCrossRef
7.
go back to reference W. Rosner, D.J. Hryb, M.S. Khan, A.M. Nakhla, N.A. Romas, Sex hormone-binding globulin. Binding to cell membranes and generation of a second messenger. J. Androl. 13, 101–106 (1992)PubMed W. Rosner, D.J. Hryb, M.S. Khan, A.M. Nakhla, N.A. Romas, Sex hormone-binding globulin. Binding to cell membranes and generation of a second messenger. J. Androl. 13, 101–106 (1992)PubMed
8.
go back to reference M. Pugeat, N. Nader, K. Hogeveen, G. Raverot, H. Dechaud, C. Grenot, Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome. Mol. Cell. Endocrinol. 316, 53–59 (2010)PubMedCrossRef M. Pugeat, N. Nader, K. Hogeveen, G. Raverot, H. Dechaud, C. Grenot, Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome. Mol. Cell. Endocrinol. 316, 53–59 (2010)PubMedCrossRef
9.
go back to reference M. Varsavsky, R. Reyes-Garcia, A. Garcia-Martin, A.R. Gonzalez-Ramirez, M.D. Aviles-Perez, M. Munoz-Torres, SHBG levels are associated with bone loss and vertebral fractures in patients with prostate cancer. Osteoporos. Int. 24, 713–719 (2013)PubMedCrossRef M. Varsavsky, R. Reyes-Garcia, A. Garcia-Martin, A.R. Gonzalez-Ramirez, M.D. Aviles-Perez, M. Munoz-Torres, SHBG levels are associated with bone loss and vertebral fractures in patients with prostate cancer. Osteoporos. Int. 24, 713–719 (2013)PubMedCrossRef
10.
go back to reference M.A. El, Z. Ouzzif, A. Mounach, A. Ben-Ghabrit, L. Achemlal, A. Bezza, I. Ghozlani, The relationship between sex steroids, bone turnover and vertebral fracture prevalence in asymptomatic men. Bone 49, 853–857 (2011)CrossRef M.A. El, Z. Ouzzif, A. Mounach, A. Ben-Ghabrit, L. Achemlal, A. Bezza, I. Ghozlani, The relationship between sex steroids, bone turnover and vertebral fracture prevalence in asymptomatic men. Bone 49, 853–857 (2011)CrossRef
11.
go back to reference D. Vanderschueren, S.R. Pye, K. Venken, H. Borghs, J. Gaytant, I.T. Huhtaniemi, J.E. Adams, K.A. Ward, G. Bartfai, F.F. Casanueva, J.D. Finn, G. Forti, A. Giwercman, T.S. Han, K. Kula, F. Labrie, M.E. Lean, N. Pendleton, M. Punab, A.J. Silman, F.C. Wu, T.W. O’Neill, S. Boonen, Gonadal sex steroid status and bone health in middle-aged and elderly European men. Osteoporos. Int. 21, 1331–1339 (2010)PubMedCrossRef D. Vanderschueren, S.R. Pye, K. Venken, H. Borghs, J. Gaytant, I.T. Huhtaniemi, J.E. Adams, K.A. Ward, G. Bartfai, F.F. Casanueva, J.D. Finn, G. Forti, A. Giwercman, T.S. Han, K. Kula, F. Labrie, M.E. Lean, N. Pendleton, M. Punab, A.J. Silman, F.C. Wu, T.W. O’Neill, S. Boonen, Gonadal sex steroid status and bone health in middle-aged and elderly European men. Osteoporos. Int. 21, 1331–1339 (2010)PubMedCrossRef
12.
go back to reference E. Barrett-Connor, G.A. Laughlin, H. Li, C.M. Nielson, P.Y. Wang, T.T. Dam, J.A. Cauley, K.E. Ensrud, M.L. Stefanick, E. Lau, A.R. Hoffman, E.S. Orwoll, The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the osteoporotic fractures in men (MrOS) study. J. Bone Miner. Res. 27, 2306–2313 (2012)PubMedCrossRefPubMedCentral E. Barrett-Connor, G.A. Laughlin, H. Li, C.M. Nielson, P.Y. Wang, T.T. Dam, J.A. Cauley, K.E. Ensrud, M.L. Stefanick, E. Lau, A.R. Hoffman, E.S. Orwoll, The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the osteoporotic fractures in men (MrOS) study. J. Bone Miner. Res. 27, 2306–2313 (2012)PubMedCrossRefPubMedCentral
13.
go back to reference J. Woo, T. Kwok, J.C. Leung, C. Ohlsson, L. Vandenput, P.C. Leung, Sex steroids and bone health in older Chinese men. Osteoporos. Int. 23, 1553–1562 (2012)PubMedCrossRef J. Woo, T. Kwok, J.C. Leung, C. Ohlsson, L. Vandenput, P.C. Leung, Sex steroids and bone health in older Chinese men. Osteoporos. Int. 23, 1553–1562 (2012)PubMedCrossRef
14.
go back to reference K.Y. Chin, I.N. Soelaiman, I.N. Mohamed, W.Z. Ngah, Serum testosterone, sex hormone-binding globulin and total calcium levels predict the calcaneal speed of sound in men. Clinics (Sao Paulo) 67, 911–916 (2012)CrossRef K.Y. Chin, I.N. Soelaiman, I.N. Mohamed, W.Z. Ngah, Serum testosterone, sex hormone-binding globulin and total calcium levels predict the calcaneal speed of sound in men. Clinics (Sao Paulo) 67, 911–916 (2012)CrossRef
15.
go back to reference A. Vermeulen, L. Verdonck, J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)PubMedCrossRef A. Vermeulen, L. Verdonck, J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)PubMedCrossRef
16.
go back to reference C.J. Paller, M.S. Shiels, S. Rohrmann, S. Basaria, N. Rifai, W. Nelson, E.A. Platz, A. Dobs, Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men. Clin. Endocrinol. (Oxf.) 70, 26–34 (2009)CrossRef C.J. Paller, M.S. Shiels, S. Rohrmann, S. Basaria, N. Rifai, W. Nelson, E.A. Platz, A. Dobs, Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men. Clin. Endocrinol. (Oxf.) 70, 26–34 (2009)CrossRef
17.
go back to reference D. Mellstrom, O. Johnell, O. Ljunggren, A.L. Eriksson, M. Lorentzon, H. Mallmin, A. Holmberg, I. Redlund-Johnell, E. Orwoll, C. Ohlsson, Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J. Bone Miner. Res. 21, 529–535 (2006)PubMedCrossRef D. Mellstrom, O. Johnell, O. Ljunggren, A.L. Eriksson, M. Lorentzon, H. Mallmin, A. Holmberg, I. Redlund-Johnell, E. Orwoll, C. Ohlsson, Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J. Bone Miner. Res. 21, 529–535 (2006)PubMedCrossRef
18.
go back to reference A.W. van den Beld, F.H. de Jong, D.E. Grobbee, H.A. Pols, S.W. Lamberts, Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J. Clin. Endocrinol. Metab. 85, 3276–3282 (2000)PubMed A.W. van den Beld, F.H. de Jong, D.E. Grobbee, H.A. Pols, S.W. Lamberts, Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J. Clin. Endocrinol. Metab. 85, 3276–3282 (2000)PubMed
19.
go back to reference G.A. Greendale, S. Edelstein, E. Barrett-Connor, Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. J. Bone Miner. Res. 12, 1833–1843 (1997)PubMedCrossRef G.A. Greendale, S. Edelstein, E. Barrett-Connor, Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. J. Bone Miner. Res. 12, 1833–1843 (1997)PubMedCrossRef
20.
go back to reference A. Bjornerem, N. Emaus, G.K. Berntsen, R.M. Joakimsen, V. Fonnebo, T. Wilsgaard, P. Oian, E. Seeman, B. Straume, Circulating sex steroids, sex hormone-binding globulin, and longitudinal changes in forearm bone mineral density in postmenopausal women and men: the Tromso study. Calcif. Tissue Int. 81, 65–72 (2007)PubMedCrossRef A. Bjornerem, N. Emaus, G.K. Berntsen, R.M. Joakimsen, V. Fonnebo, T. Wilsgaard, P. Oian, E. Seeman, B. Straume, Circulating sex steroids, sex hormone-binding globulin, and longitudinal changes in forearm bone mineral density in postmenopausal women and men: the Tromso study. Calcif. Tissue Int. 81, 65–72 (2007)PubMedCrossRef
21.
go back to reference D. Mellstrom, L. Vandenput, H. Mallmin, A.H. Holmberg, M. Lorentzon, A. Oden, H. Johansson, E.S. Orwoll, F. Labrie, M.K. Karlsson, O. Ljunggren, C. Ohlsson, Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J. Bone Miner. Res. 23, 1552–1560 (2008)PubMedCrossRef D. Mellstrom, L. Vandenput, H. Mallmin, A.H. Holmberg, M. Lorentzon, A. Oden, H. Johansson, E.S. Orwoll, F. Labrie, M.K. Karlsson, O. Ljunggren, C. Ohlsson, Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J. Bone Miner. Res. 23, 1552–1560 (2008)PubMedCrossRef
22.
go back to reference A.B. Araujo, T.G. Travison, B.Z. Leder, J.B. McKinlay, Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men. J. Clin. Endocrinol. Metab. 93, 2135–2141 (2008)PubMedCrossRefPubMedCentral A.B. Araujo, T.G. Travison, B.Z. Leder, J.B. McKinlay, Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men. J. Clin. Endocrinol. Metab. 93, 2135–2141 (2008)PubMedCrossRefPubMedCentral
23.
go back to reference C. Lormeau, B. Soudan, M. D’Herbomez, P. Pigny, B. Duquesnoy, B. Cortet, Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Bone 34, 933–939 (2004)PubMedCrossRef C. Lormeau, B. Soudan, M. D’Herbomez, P. Pigny, B. Duquesnoy, B. Cortet, Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Bone 34, 933–939 (2004)PubMedCrossRef
24.
go back to reference H.W. Goderie-Plomp, M. van der Klift, W. de Ronde, A. Hofman, F.H. de Jong, H.A. Pols, Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam study. J. Clin. Endocrinol. Metab. 89, 3261–3269 (2004)PubMedCrossRef H.W. Goderie-Plomp, M. van der Klift, W. de Ronde, A. Hofman, F.H. de Jong, H.A. Pols, Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam study. J. Clin. Endocrinol. Metab. 89, 3261–3269 (2004)PubMedCrossRef
25.
go back to reference L. Gennari, D. Merlotti, G. Martini, S. Gonnelli, B. Franci, S. Campagna, B. Lucani, N. Dal Canto, R. Valenti, C. Gennari, R. Nuti, Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J. Clin. Endocrinol. Metab. 88, 5327–5333 (2003)PubMedCrossRef L. Gennari, D. Merlotti, G. Martini, S. Gonnelli, B. Franci, S. Campagna, B. Lucani, N. Dal Canto, R. Valenti, C. Gennari, R. Nuti, Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J. Clin. Endocrinol. Metab. 88, 5327–5333 (2003)PubMedCrossRef
26.
go back to reference M.T. Drake, M.H. Murad, K.F. Mauck, M.A. Lane, C. Undavalli, T. Elraiyah, L.M. Stuart, C. Prasad, A. Shahrour, R.J. Mullan, A. Hazem, P.J. Erwin, V.M. Montori, Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 97, 1861–1870 (2012)PubMedCrossRef M.T. Drake, M.H. Murad, K.F. Mauck, M.A. Lane, C. Undavalli, T. Elraiyah, L.M. Stuart, C. Prasad, A. Shahrour, R.J. Mullan, A. Hazem, P.J. Erwin, V.M. Montori, Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 97, 1861–1870 (2012)PubMedCrossRef
27.
go back to reference E. Hoppe, B. Bouvard, M. Royer, M. Audran, E. Legrand, Sex hormone-binding globulin in osteoporosis. Joint Bone Spine 77, 306–312 (2010)PubMedCrossRef E. Hoppe, B. Bouvard, M. Royer, M. Audran, E. Legrand, Sex hormone-binding globulin in osteoporosis. Joint Bone Spine 77, 306–312 (2010)PubMedCrossRef
28.
go back to reference W. Rosner, D.J. Hryb, S.M. Kahn, A.M. Nakhla, N.A. Romas, Interactions of sex hormone-binding globulin with target cells. Mol. Cell. Endocrinol. 316, 79–85 (2010)PubMedCrossRef W. Rosner, D.J. Hryb, S.M. Kahn, A.M. Nakhla, N.A. Romas, Interactions of sex hormone-binding globulin with target cells. Mol. Cell. Endocrinol. 316, 79–85 (2010)PubMedCrossRef
29.
go back to reference X.N. Pang, Y. Hu, Y. Yuan, J.P. Shen, X.Y. Zha, X. Sun, Lower levels sex hormone-binding globulin independently associated with metabolic syndrome in pre-elderly and elderly men in China. J. Geriatr. Cardiol. 10, 28–33 (2013)PubMedPubMedCentral X.N. Pang, Y. Hu, Y. Yuan, J.P. Shen, X.Y. Zha, X. Sun, Lower levels sex hormone-binding globulin independently associated with metabolic syndrome in pre-elderly and elderly men in China. J. Geriatr. Cardiol. 10, 28–33 (2013)PubMedPubMedCentral
30.
go back to reference P. Xue, P. Gao, Y. Li, The association between metabolic syndrome and bone mineral density: a meta-analysis. Endocrine 42, 546–554 (2012)PubMedCrossRef P. Xue, P. Gao, Y. Li, The association between metabolic syndrome and bone mineral density: a meta-analysis. Endocrine 42, 546–554 (2012)PubMedCrossRef
32.
go back to reference T.G. Travison, A.B. Araujo, T.J. Beck, R.E. Williams, R.V. Clark, B.Z. Leder, J.B. McKinlay, Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength. J. Clin. Endocrinol. Metab. 94, 853–860 (2009)PubMedCrossRefPubMedCentral T.G. Travison, A.B. Araujo, T.J. Beck, R.E. Williams, R.V. Clark, B.Z. Leder, J.B. McKinlay, Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength. J. Clin. Endocrinol. Metab. 94, 853–860 (2009)PubMedCrossRefPubMedCentral
33.
go back to reference S. Khosla, L.R. Melton, R.A. Robb, J.J. Camp, E.J. Atkinson, A.L. Oberg, P.A. Rouleau, B.L. Riggs, Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men. J. Bone Miner. Res. 20, 730–740 (2005)PubMedCrossRef S. Khosla, L.R. Melton, R.A. Robb, J.J. Camp, E.J. Atkinson, A.L. Oberg, P.A. Rouleau, B.L. Riggs, Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men. J. Bone Miner. Res. 20, 730–740 (2005)PubMedCrossRef
34.
go back to reference I. Kyvernitakis, U. Saeger, V. Ziller, T. Bauer, B. Seker-Pektas, P. Hadji, The effect of age, sex hormones, and bone turnover markers on calcaneal quantitative ultrasonometry in healthy German men. J. Clin. Densitom. 16, 320–328 (2013)PubMedCrossRef I. Kyvernitakis, U. Saeger, V. Ziller, T. Bauer, B. Seker-Pektas, P. Hadji, The effect of age, sex hormones, and bone turnover markers on calcaneal quantitative ultrasonometry in healthy German men. J. Clin. Densitom. 16, 320–328 (2013)PubMedCrossRef
Metadata
Title
Sex hormone-binding globulin (SHBG) as an independent determinant of bone mineral density (BMD) among Chinese middle-aged and elderly men
Authors
Xiao-Yun Zha
Yu Hu
Xiao-Na Pang
Ji-Heng Zhu
Gui-Lin Chang
Li Li
Publication date
01-11-2014
Publisher
Springer US
Published in
Endocrine / Issue 2/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0155-0

Other articles of this Issue 2/2014

Endocrine 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.